gene_symbol
EGFR
hgnc_id
HGNC:3236
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Amivantamab binds EGFR on target cells and engages Fcγ receptor–bearing immune cells, inducing antibody-dependent cellular cytotoxicity (NK-cell killing) and trogocytosis/phagocytosis, leading to death of EGFR-expressing cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
extracellular domain binding
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06532032
disease_id_num_tar_ref
1757
drug_id_num_tar_ref
4723